Quantum-classical Hybrid Machine Learning (QHML) models are recognized for their robust performance and high generalization ability even for relatively small datasets. These qualities offer unique advantages for anti-cancer drug response prediction, where the number of available samples is typically small. However, such hybrid models appear to be very sensitive to the data encoding used at the interface of a neural network and a quantum circuit, with suboptimal choices leading to stability issues. To address this problem, we propose a novel strategy that uses a normalization function based on a moderated gradient version of the $\tanh$. This method transforms the outputs of the neural networks without concentrating them at the extreme value ranges. Our idea was evaluated on a dataset of gene expression and drug response measurements for various cancer cell lines, where we compared the prediction performance of a classical deep learning model and several QHML models. These results confirmed that QHML performed better than the classical models when data was optimally normalized. This study opens up new possibilities for biomedical data analysis using quantum computers.
Quantum-classical Hybrid Machine Learning (QHML) models are recognized for their robust performance and high generalization ability even for relatively small datasets. These qualities offer unique advantages for anti-cancer drug response prediction, where the number of available samples is typically small. However, such hybrid models appear to be very sensitive to the data encoding used at the interface of a neural network and a quantum circuit, with suboptimal choices leading to stability issues. To address this problem, we propose a novel strategy that uses a normalization function based on a moderated gradient version of the tanh. This method transforms the outputs of the neural networks without concentrating them at the extreme value ranges. Our idea was evaluated on a dataset of gene expression and drug response measurements for various cancer cell lines, where we compared the prediction performance of a classical deep learning model and several QHML models. These results confirmed that QHML performed better than the classical models when data was optimally normalized. This study opens up new possibilities for biomedical data analysis using quantum computers.
Cancer is one of the leading causes of death worldwide. It is caused by various genetic mutations, which makes every instance of the disease unique. Since chemotherapy can have extremely severe side effects, each patient requires a personalized treatment plan. Finding the dosages that maximize the beneficial effects of the drugs and minimize their adverse side effects is vital. Deep neural networks automate and improve drug selection. However, they require a lot of data to be trained on. Therefore, there is a need for machine-learning approaches that require less data. Hybrid quantum neural networks were shown to provide a potential advantage in problems where training data availability is limited. We propose a novel hybrid quantum neural network for drug response prediction based on a combination of convolutional, graph convolutional, and deep quantum neural layers of 8 qubits with 363 layers. We test our model on the reduced Genomics of Drug Sensitivity in Cancer dataset and show that the hybrid quantum model outperforms its classical analog by 15% in predicting IC50 drug effectiveness values. The proposed hybrid quantum machine learning model is a step towards deep quantum data-efficient algorithms with thousands of quantum gates for solving problems in personalized medicine, where data collection is a challenge.
This work investigates a hybrid quantum-classical machine learning methodology that combines deep learning with quantum computing to improve predictive analytics. The method starts by changing basic input features into the best mixed forms using classical weight matrices and quantum state encoding. A unitary operator refines quantum states to enhance feature extraction and representation. Gradient-based alterations repeatedly modify feature weights during optimization to improve accuracy. Quantum circuits not only change data but also enhance system separability and resilience. Normalizing and enhancing extracted properties using quantum and classical transformations ensures stability and consistency. Performance trials demonstrate that the hybrid technique improves accuracy, precision, recall, computational complexity, execution time, and energy economy. The hybrid model always outperforms machine learning, deep learning, and quantum mechanics-based approaches. The technique is now more scalable, making enormous data sets easier to analyze. Faster convergence rates and noise tolerance improve model performance in real-world applications. The findings suggest that quantum advances and classical learning approaches improve model interpretability and decision-making reliability. The research found hybrid quantum-classical machine learning to be a powerful, scalable, and efficient predictive modeling solution. This method improves precision while conserving computing power. By using both paradigms, the technique provides deeper insights and better predictions. As a major facilitator for future AI-driven applications, the hybrid model provides a possible solution for difficult machine learning challenges. These developments make hybrid models available.
Drug repositioning is a less expensive and time-consuming method than the traditional method of drug discovery. It is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. A key strategy in repositioning approved or investigational drugs is determining the binding affinity of these drugs to target proteins. The large increase in available experimental data has helped deep learning methods to demonstrate superior performance compared to conventional prediction and other traditional computational methods in precise binding affinity prediction. However, these methods are complex and time-consuming, presenting a significant barrier to their development and practical application. In this context, quantum computing (QC) and quantum machine learning (QML) theoretically offer promising solutions to effectively address these challenges. In this work, we introduce a hybrid quantum–classical framework to predict binding affinity. Our approach involves, initially, the implementation of an efficient classical model using convolutional neural networks (CNNs) for feature extraction and three fully connected layers for prediction. Subsequently, retaining the classical module for feature extraction, we implement various quantum and classical modules for binding affinity prediction, which accept the concatenated features as input. Quantum predicted modules are implemented with Variational Quantum Regressions (VQRs), while classical predicted modules are implemented with various fully connected layers. Our findings clearly show that hybrid quantum–classical models accelerate the training process in terms of epochs and achieve faster stabilization. Also, these models demonstrate quantum superiority in terms of complexity, accuracy, and generalization, thereby indicating a promising direction for QML.
Quantum machine learning has emerged as a promising approach to enhance computational efficiency by leveraging the principles of quantum computing. However, the limitations of current Noisy Intermediate-Scale Quantum (NISQ) devices, such as noise, limited qubit availability, and circuit depth constraints, restrict the implementation of fully quantum models. To address these challenges, this study focuses on the design, implementation, and performance evaluation of hybrid quantum-classical machine learning (HQML) models. The proposed approach integrates parameterized quantum circuits with classical optimization techniques to enable efficient learning within NISQ environments. The study employs standard benchmark datasets, including Iris, Breast Cancer, and MNIST, to evaluate the performance of the hybrid model. The results indicate that the HQML model achieves competitive accuracy on small and medium-sized datasets while maintaining balanced precision, recall, and F1-score. However, performance declines for complex datasets due to hardware limitations and noise effects. Additionally, the hybrid model demonstrates a lower number of parameters compared to classical deep learning models but requires higher training time due to iterative quantum-classical optimization. The findings highlight that hybrid quantum-classical models provide a practical and scalable approach for utilizing quantum computing in the current technological landscape. Although challenges related to noise, scalability, and computational overhead persist, advancements in quantum hardware and algorithm design are expected to improve performance. This study contributes to the growing field of quantum machine learning by providing a systematic framework for evaluating hybrid models on NISQ devices and identifying key areas for future research.
Breast cancer is a major health concern, and early detection can make a great difference in treatment and survival rates for breast cancer patients. Machine learning methods have noticeably improved prediction accuracy on high-dimensional medical datasets and have become widely used tools in medical diagnostics. The transition to a quantum computational framework has opened new directions in machine learning research. By using qubits instead of classical bits, quantum models may provide new ways to represent and process complex medical data. In medical diagnostics, this has led to a growing interest in whether quantum approaches can improve classification performance more effectively than classical methods. The purpose of this paper is to compare classical and quantum machine learning models on the task of breast cancer classification and to determine whether quantum models can achieve higher accuracy and faster prediction on a selected dataset. Alongside the main simulator-based experiment, a smaller experiment was performed on a real IBM quantum computer to demonstrate the practical execution of the same task under current hardware constraints. In the practical part of the study, the Wisconsin Diagnostic Breast Cancer (WDBC) dataset was used. This dataset consists of 569 samples with 30 numerical features extracted from digitized fine needle aspirate images and provides a reliable basis for evaluating model performance. A comparative analysis was conducted between classical and quantum machine learning models, including a support vector machine (SVM), an artificial neural network (ANN), a quantum support vector machine (QSVM), and a hybrid quantum-classical neural network (QNN). In the simulator-based experiment, both SVM and ANN achieved an accuracy of 0.956 with an F1-score of 0.965 on the test set, while QSVM reached an accuracy of 0.807 with an F1-score of 0.866 and the Hybrid QNN achieved 0.623 accuracy with an F1-score of 0.677. These quantum and hybrid models also required substantially longer training times than the classical baselines. A small hardware experiment on an IBM quantum device further illustrates both the practical feasibility and the current limitations of executing this classification task on noisy intermediate-scale quantum hardware.
The rapid advancements in artificial intelligence (AI) and quantum computing have catalyzed an unprecedented shift in the methodologies utilized for healthcare diagnostics and treatment optimization. This research paper explores the integration of quantum neural networks (QNNs) with classical machine learning (ML) algorithms to enhance diagnostic accuracy, facilitate personalized treatment plans, and predict patient outcomes with a higher degree of precision. Quantum neural networks, leveraging the principles of quantum mechanics such as superposition, entanglement, and quantum parallelism, have demonstrated the potential to perform complex computations more efficiently than classical counterparts. When coupled with established machine learning algorithms, QNNs can overcome traditional limitations in data processing, enabling more sophisticated models capable of uncovering intricate patterns in large and high-dimensional datasets. Machine learning, with its vast applications in the medical field, has long been instrumental in improving diagnostics and tailoring treatment regimens to patient-specific characteristics. However, despite significant advancements, classical ML approaches face substantial challenges, particularly in terms of computational complexity and the ability to process large-scale, multi-modal healthcare data effectively. Quantum neural networks address these challenges by introducing quantum computational paradigms that facilitate exponentially faster processing, allowing for real-time analysis of vast and complex datasets. The synergy between QNNs and ML algorithms introduces novel approaches that are poised to revolutionize predictive analytics in healthcare, optimizing patient outcomes and enabling highly personalized treatment plans. A key aspect of integrating quantum neural networks into machine learning frameworks is the potential for improved precision in diagnostic systems. Traditional diagnostic procedures often rely on predefined models that may overlook nuanced correlations within patient data. Quantum neural networks, with their ability to represent and process data in a quantum space, provide a more robust framework that can adaptively learn from intricate relationships in patient information. For instance, QNNs can significantly enhance the efficacy of disease detection algorithms, such as those used for identifying early-stage cancers or predicting the onset of chronic conditions like diabetes and heart disease, by offering superior pattern recognition capabilities. Furthermore, QNNs combined with classical machine learning architectures facilitate the creation of hybrid models that harness the strengths of both approaches, leading to diagnostic tools that are not only more precise but also more adaptive to varied data sources. The integration of QNNs with machine learning extends beyond diagnostics to personalized treatment optimization. Traditional treatment planning methodologies, including rule-based and data-driven ML models, often face difficulties in accounting for the multifaceted nature of patient data and individual variability. Quantum neural networks enhance this process by leveraging quantum algorithms that provide an efficient search space for complex treatment optimization problems, allowing for a more detailed understanding of patient responses and potential treatment outcomes. The ability of QNNs to perform parallel processing enables the assessment of a wide range of treatment scenarios simultaneously, leading to more accurate predictions regarding patient reactions to specific drugs, therapies, or medical interventions. This facilitates an adaptive approach that can recommend personalized treatment regimens based on comprehensive patient profiles, ultimately enhancing patient outcomes and reducing the likelihood of adverse drug reactions. In addition to enhancing diagnostics and treatment recommendations, quantum neural networks show promise in forecasting patient outcomes by offering a more robust analysis of longitudinal patient data. Forecasting models that leverage the combined power of quantum and classical algorithms can process historical data more rapidly, allowing healthcare providers to anticipate potential health issues and intervene earlier. For example, predictive models utilizing QNNs can anticipate patient deterioration in critical care settings, facilitating timely interventions that mitigate risks and improve survival rates. Such predictive models can be instrumental in managing chronic diseases, monitoring recovery trajectories, and optimizing resource allocation within healthcare systems, thus contributing to overall efficiency and better resource management. Despite the promising capabilities of integrating QNNs with ML algorithms, there are notable challenges that need to be addressed to fully realize their potential. The practical implementation of quantum algorithms in a healthcare context faces hurdles related to hardware limitations, the need for high fidelity in quantum states, and the scalability of quantum systems to handle real-world clinical data. Additionally, the hybrid nature of combining classical and quantum approaches requires sophisticated algorithms that can bridge the gap between quantum computation and classical data processing pipelines. Solutions to these challenges may include advancements in quantum hardware, such as the development of more stable qubits and noise reduction techniques, as well as the optimization of hybrid algorithms that leverage both classical machine learning and quantum computing capabilities effectively. The exploration of quantum neural networks for healthcare applications also necessitates rigorous ethical considerations, particularly in ensuring data privacy and security. The incorporation of quantum computing must comply with healthcare data protection regulations, and quantum algorithms must be designed to maintain patient confidentiality while processing sensitive health data. Moreover, the interpretability of quantum models poses challenges that could hinder their acceptance in clinical practice. Advances in explainable AI and quantum algorithm transparency are crucial to foster trust among healthcare professionals and patients alike. Integration of quantum neural networks with classical machine learning models represents a transformative approach that could significantly advance healthcare diagnostics, personalized treatment strategies, and patient outcome prediction. By harnessing the computational advantages offered by quantum systems and the flexibility of machine learning algorithms, healthcare applications can achieve a new level of precision and adaptability. Despite current challenges, continued research into quantum algorithms, quantum hardware development, and hybrid computational models promises substantial strides in overcoming these limitations. The synergy between QNNs and ML algorithms could ultimately lead to more effective, personalized, and efficient healthcare solutions, ushering in a new era of data-driven medical care characterized by increased diagnostic accuracy and improved treatment outcomes. As the field evolves, interdisciplinary collaboration between quantum physicists, computer scientists, and healthcare professionals will be vital to unlock the full potential of these innovative computational techniques and bring them to mainstream clinical use.